Tag: Diagnostics
Yoda Diagnostics hosts ‘Yoda Early Mind Summit’ in New Delhi
Driving focus on early autism detection and clinical insights
TDB-DST supports Acrannolife Genomics for indigenous manufacturing of advanced IVD diagnostic...
The project focuses on establishing an advanced manufacturing facility to support the large-scale production and deployment of indigenous in-vitro diagnostic (IVD) solutions developed by the company.
MedGenome makes a majority investment in Mumbai-based Medcare Diagnostics
This brings together Medcare’s trusted nuclear medicine and imaging diagnostics expertise with MedGenome’s advanced science, technology, and multi-omics capabilities
Congenital Hypothyroidism: A simple newborn test can prevent lifelong intellectual disability
Early diagnosis remains the key to preventing lifelong intellectual disability
Novo Nordisk India partners with ORDI to champion rare disease advocacy...
Racefor7 promotes awareness, encourages early diagnosis, and calls for improved access to rare disease care across the country
Samsung Health announces ‘Find Care’ feature in partnership with PharmEasy and...
Starting February 24, the Samsung Health app will allow consumers order medicines, book diagnostic tests and online medical consultations
Early cancer detection begins with getting the first step right
Getting the first step right does not guarantee outcomes, but it dramatically improves the odds, writes Shunsuke Honda, Business Advisor, Medical Systems Division, FUJIFILM India
Cipla Foundation partners Tata IISc Medical School to set up Centre...
The Centre will offer diagnostics, outpatient and inpatient services, a dedicated ICU, and high-dependency units to deliver cutting-edge treatment for respiratory illnesses
ErlySign granted US FDA breakthrough device designation for its saliva-based oral...
The designation marks a significant global regulatory milestone for the company and underscores the potential of its technology to advance early cancer detection across international markets
QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST in a...
QuantiFERON-TB Gold Plus reduced the modeled lifetime risk of progression to active TB among individuals with TBI by approximately 41% compared with Tuberculin Skin Test (TST)